Proteometer™ Kits 

Coming in Fall 2022 

Nanotechnology kits that will turn any liquid chromatograph (LC) into a Proteometer (proteoform meter) capable of rapid proteoform structure analysis on Critical Quality Attributes (CQA’s).

Focused CQA's based on Customer requests include:

  • Aggregate Detection & Quantification

  • Charge Variant Analysis

  • Oxidation Detection and Defect Quantification

  • HCP Titer

  • Glycosylation Detection & Quantification

Existing LCs can typically be converted in less than an hour.  Novilytic can support the conversion although this is rarely needed.

Bars with Logos.jpg


Architectural Structure

"As analytical tools have matured for the quality control and characterization of isolated biopharmaceuticals, the application of advanced analytical systems to dynamically contribute to process monitoring and control in complex bioreactors is critical for enhanced process efficiency and product quality.


The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies. The integration of complementary bioprocess analytical data facilitates decision-making through a powerful link between the manufacturing space and the QC laboratory."

Eugene L. Inman, Ph.D.

Pharmaceutical Quality Consultant

Retired Eli Lilly and Company

Architectural Structure

“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.


The approach improves product safety, reduces COPQ and post release testing, and paves the way for real-time product release, reducing inventory costs. 


The solution combines novel sample handing and artificial intelligence with proven analytical technology that is easy to deploy and support, and provides near instantaneous ROI.”

Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)